Business description: PCAS
- synthesized pharmaceutical products (63.5%);
- fine chemicals (36.5%): technical fluids and additives for the lubricant industry, chemical additive synthesis. The group also offers photochemical and new technology products (photosensitive materials, photo-initiators, and polymers for photography, reprography, and micro-electronics).
At the end of 2022, the group had 7 production sites located in France (5), Canada and Finland.
France accounts for 76% of net sales.
Number of employees: 1,178
Sales by Activity: PCAS
| Fiscal Period: December | 2019 (EUR) | 2020 (EUR) | 2021 (EUR) | 2022 (EUR) |
|---|---|---|---|---|
Pharmaceutical Synthesis | 128M | 135M | 120M | 144M |
Fine Speciality Chemicals | 73.25M | 58.92M | 67.41M | 82.72M |
Geographical breakdown of sales: PCAS
| Fiscal Period: December | 2019 (EUR) | 2020 (EUR) | 2021 (EUR) | 2022 (EUR) |
|---|---|---|---|---|
France | 163M | 155M | 143M | 172M |
Other Areas | 38.01M | 38.92M | 44.36M | 54.3M |
Executive Committee: PCAS
| Manager | Title | Age | Since |
|---|---|---|---|
Gildas Barreyre
CEO | Chief Executive Officer | 43 | 02/05/2025 |
Eric Moissenot
DFI | Director of Finance/CFO | - | - |
Gérard Guillamot
CTO | Chief Tech/Sci/R&D Officer | - | 28/02/1999 |
Composition of the Board of Directors: PCAS
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 74 | 28/02/2014 | |
Janine Cossy
BRD | Director/Board Member | - | - |
Company details: PCAS
Other Pharmaceuticals
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.49% | +8.54% | +59.89% | +117.27% | 1,106B | |
| +2.19% | -1.66% | +34.23% | +70.27% | 612B | |
| +2.26% | +2.83% | +25.92% | +98.65% | 500B | |
| +2.58% | +8.31% | +37.43% | +63.51% | 367B | |
| +3.25% | +1.96% | +74.90% | +47.67% | 354B | |
| +1.85% | +5.45% | +21.38% | +49.26% | 286B | |
| +1.76% | +4.92% | +0.48% | +20.31% | 256B | |
| +3.29% | +5.12% | +46.90% | +56.43% | 230B | |
| +2.25% | +4.04% | +27.44% | +99.53% | 190B | |
| Average | +1.13% | +2.13% | +36.51% | +69.21% | 433.35B | |
| Weighted average by Cap. | +0.57% | +2.30% | +41.69% | +80.33% |
